Digitek, a drug used to treat heart failure and abnormal heart rhythms has been linked to Digitek toxicity. Digitek toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitek intake.
A class I Digitek recall is being issued on all Digitek (digoxin) tablets, which may contain twice the approved level of Digitek. The voluntary all lot Digitek recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. The existence of double-strength pills pose a risk of Digitek toxicity, which can result in nausea, vomiting, low blood pressure, cardiac instability, bradycardia and even death. While both the FDA and USDA have their own definitions of product Digitek recall classes, they follow the same general rule - 1= most serious / dangerous, 2= potentially dangerous and 3 = least dangerous. Regardless of the classification level of a Digitek recall, consumers are advised to take each of them seriously and follow the instructions provided by the agency responsible for the Digitek recall.
Digitek is a registered trademark of Actavis Totowa (formerly Amide Pharmaceutical, Inc.) for their digoxin tablets, which are prescribed to treat heart failure and abnormal heart rhythms. The drug is distributed by Mylan Pharmaceuticals Inc., under a Bertek label and by UDL Laboratories, Inc. under a 'UDL'label. In April of 2008 a letter was issued by Actavis Totowa issuing a voluntary recall of their drug Digitek. At the time of the Digitek recall, the FDA had already received several reports of illnesses and medical events related to Digitek treatment. The Food & Drug Administration (FDA) deemed the Digitek recall a Class I recall, meaning that the defective Digitek tablets could cause serious health problems or death.
Digitek (Digoxin) is available in tablet, capsule, liquid, and injectable forms, however the Digitek recall pertains only to the tablets. The reason for the Digitek recall was due to the possibility that some of the tablets contained twice the approved dosage. Medical providers have found that tablets subject to the Digitek recall, if ingested, can result in severe medical complications, generally caused by digitalis toxicity, which is a medical condition that can lead to very serious side effects including but not limited to nausea, vomiting, dizziness, low blood pressure, cardiac instability and death. Because of the severe risk of Digitek Digoxin toxicity associated with this manufacturing error, individuals who currently take or have taken the drug should consider developing a Digitek lawsuit by contacting a Digitek lawyer. Some of these lawsuits allege that the Digitek recall would not have been necessary if Actavis Totowa had adequately responded to earlier warnings from the FDA about the quality of the Digitek being produced.
The plaintiffs in the Digitek Digoxin lawsuit are seeking compensation for their injuries as well as medical monitoring in case they experience future health problems. With a Digitek recall lawsuit, our lawyers may help you get reimbursed for expenses such as medical bills, loss of income, and pain and suffering. We are pursuing individual litigation nationwide and currently accepting new Digitek recall and Digitalis toxicity cases in all 50 states. If you would like to discuss your legal rights or want more information on the Digitek recall lawsuit, our experienced lawyers will be happy to answer your questions. Click Digitek Attorneys for a free Digitek recall attorney consultation.
